Winstrol is the trade name for stanozolol, a synthetic derivative of dihydrotestosterone available as both an oral tablet and an injectable water-based suspension. It has genuine medical history — it was used for hereditary angioedema and some wasting conditions — and it is one of the most recognisable names in the drug-testing scandals of the past several decades. This guide explains what it does to a physique, why people use it despite a rough side-effect profile, and the specific harms that define it. It is reference information, not advice to use.
Stanozolol does not aromatise to estrogen at all. That single property explains most of its reputation: no estrogenic water retention, so the visual effect is a dry, hard, vascular look rather than added size. People do not run Winstrol to get bigger; they run it to look harder and more defined, usually in the final weeks before a photo or a stage appearance.
What it actually does
The honest description is cosmetic. Stanozolol is a modest mass and strength builder at best; its value is in appearance.
- A dry, hardened, more vascular look because it holds no water and does not convert to estrogen.
- Some strength gain and a mild anti-catabolic effect that helps preserve muscle in a calorie deficit, which is why it appears in cutting contexts.
- It lowers sex-hormone-binding globulin, which raises the fraction of free testosterone and other free androgens circulating — a real pharmacological effect, though its practical contribution is often overstated.
The crucial context is that the dry look depends on already being lean. On a person carrying body fat, stanozolol does little visible good; the effect only reads on a physique that is already low in body fat. It reveals conditioning rather than creating it.
The joint problem
Winstrol is notorious for dry, painful joints, and the complaint is close to universal among people who run it at meaningful doses. The likely mechanism is a reduction in synovial fluid and effects on collagen, the near-opposite of nandrolone's joint-comforting reputation. For anyone training heavy, this is not a minor annoyance — it can genuinely limit training and raise injury risk.
- Expect joint dryness and aching, worse at higher doses and longer durations.
- People sometimes pair it with a joint-friendly compound to offset this, which somewhat defeats the point of a clean cutting drug.
Lipids and cardiovascular strain
Stanozolol has among the harshest effects on blood lipids of any commonly used steroid. It sharply lowers HDL ("good") cholesterol and raises LDL, shifting the profile in an atherogenic direction fast. This is well documented in the clinical literature, not just anecdote, and it is one of the strongest arguments against running it for long.
- Marked HDL suppression and LDL elevation, often within a couple of weeks.
- Combined with its non-aromatising nature (estrogen is protective for lipids), the cardiovascular cost adds up quickly.
Hepatotoxicity
Stanozolol is 17-alpha-alkylated, the chemical modification that lets an oral survive first-pass liver metabolism — and the same modification that makes it hepatotoxic. Liver enzyme elevations are common on it, and cholestatic liver injury has been reported. Notably, the injectable form is still 17-alpha-alkylated, so switching to injection does not spare the liver the way it does with some other compounds.
- Expect liver marker elevations; monitor them.
- Because of liver strain, oral runs are kept short — commonly in the range of 4-8 weeks.
How it is run and stacked
Stanozolol is almost always a finishing compound layered onto a testosterone base during the lean, final phase of a cut, not a standalone cycle. Oral dosing is daily because of a short half-life (roughly 9 hours for the oral); injectable suspension is also dosed frequently.
- Typical reported oral use sits in a modest daily range for a short window; higher doses mostly worsen joints and lipids rather than improving the look.
- It is run with testosterone because, like all these drugs, it suppresses natural production and does not support libido or wellbeing on its own.
- It is stacked with other non-bloating compounds such as drostanolone (Masteron) for a combined hardening effect in the last weeks before a physique deadline.
Health considerations
The monitoring priorities for stanozolol are specific: liver markers and a lipid panel move to the top of the list, above the usual haematocrit and hormone checks. The combination of severe lipid effects and liver strain makes it a poor choice for long or high-dose use, and it is not a compound to run casually or year-round.
- Baseline and follow-up bloods: liver enzymes, full lipid panel, full blood count, testosterone, estradiol.
- Keep durations short and avoid stacking it with other hepatotoxic orals.
Bottom line
Stanozolol does one thing well — it makes an already-lean physique look dry and hard — and it charges a lot for it: painful dry joints, some of the worst lipid damage in the whole category, and genuine liver toxicity that the injectable form does not avoid. It is a short-term, late-stage cosmetic tool for people who are already lean, not a mass builder and not something to run for long. The benefit is narrow and the costs are specific and well documented.